Paxman AB (PXMBF)
3.50
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Paxman EPS Diluted (Quarterly) : -0.0006 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0006 |
| December 31, 2025 | -0.04 |
| September 30, 2025 | 0.006 |
| June 30, 2025 | -0.0145 |
| March 31, 2025 | -0.0268 |
| December 31, 2024 | 0.0592 |
| September 30, 2024 | 0.0251 |
| June 30, 2024 | 0.0481 |
| March 31, 2024 | 0.0661 |
| December 31, 2023 | -0.0081 |
| September 30, 2023 | 0.0357 |
| June 30, 2023 | 0.0256 |
| March 31, 2023 | -0.0128 |
| December 31, 2022 | -0.0479 |
| September 30, 2022 | 0.0231 |
| June 30, 2022 | 0.0032 |
| March 31, 2022 | -0.0349 |
| December 31, 2021 | -0.0084 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.0345 |
| June 30, 2021 | -0.0369 |
| March 31, 2021 | -0.0052 |
| December 31, 2020 | -0.0802 |
| September 30, 2020 | -0.0298 |
| June 30, 2020 | -0.0418 |
| March 31, 2020 | 0.0166 |
| December 31, 2019 | 0.0136 |
| September 30, 2019 | 0.0055 |
| June 30, 2019 | 0.0019 |
| March 31, 2019 | -0.0033 |
| December 31, 2018 | -0.0294 |
| September 30, 2018 | -0.0021 |
| June 30, 2018 | -0.0058 |
| March 31, 2018 | -0.0123 |
| December 31, 2017 | -0.0457 |
| September 30, 2017 | -0.0134 |
| June 30, 2017 | -0.0034 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Getinge AB | 0.1611 |
| Xvivo Perfusion AB | 0.1258 |
| Abbott Laboratories | 0.6165 |
| AngioDynamics, Inc. | -0.1944 |
| Alphatec Holdings, Inc. | -0.2201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.0137M |
| Revenue (Quarterly) | 9.798M |
| Total Expenses (Quarterly) | 9.811M |
| Enterprise Value | 70.80M |
| Gross Profit Margin (Quarterly) | 0.19% |
| Profit Margin (Quarterly) | -0.14% |
| Earnings Yield | -1.40% |
| Normalized Earnings Yield | -1.406 |